Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Outlook and Strategic Industry Developments
The development of immunoglobulin therapies over the past several decades stands as one of the most significant achievements in the management of chronic neuro-immunological disorders. Early formulations often required lengthy hospital stays and placed a heavy physical burden on patients due to systemic side effects and rigid dosing schedules. Today, ongoing innovations in protein purification...
0 Comments 0 Shares 2 Views 0 Reviews